PTC Therapeutics, Inc.

PTCT XNAS PHARMACEUTICAL PREPARATIONS

Market Cap

5.7B

Short interest (May 15)

12.3%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.27%

↓ 1.5%

Available Shares

2M

↑ 10.9%

Price Chart

Company Overview

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Company Info

Exchange: NASDAQ
Industry: PHARMACEUTICAL PREPARATIONS
CIK: 0001070081
Asset Type: CS

Market Data

Market Cap: $5,659,633,331
Employees: 991
Status: Active

Short Interest

Current Borrow Fee 0.27%
Range: 0.26% - 0.28%
Available Shares 2M
Range: 1.8M - 2M

Recent Changes

Fee Change: ↑ 0.8%
Available Change: ↓ 5.0%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime